Related references
Note: Only part of the references are listed.Evaluation of the relative virulence of novel SARS-CoV-2 variants: a retrospective cohort study in Ontario, Canada
David N. Fisman et al.
CANADIAN MEDICAL ASSOCIATION JOURNAL (2021)
Hospitalisation associated with SARS-CoV-2 delta variant in Denmark
Peter Bager et al.
LANCET INFECTIOUS DISEASES (2021)
Increased risk of hospitalisation and intensive care admission associated with reported cases of SARS-CoV-2 variants B.1.1.7 and B.1.351 in Norway, December 2020-May 2021
Lamprini Veneti et al.
PLOS ONE (2021)
Estimated transmissibility and impact of SARS-CoV-2 lineage B.1.1.7 in England
Nicholas G. Davies et al.
SCIENCE (2021)
Vaccine effectiveness against infection with the Delta (B.1.617.2) variant, Norway, April to August 2021
Elina Seppala et al.
EUROSURVEILLANCE (2021)
SARS-CoV-2 Delta VOC in Scotland: demographics, risk of hospital admission, and vaccine effectiveness
Aziz Sheikh et al.
LANCET (2021)